未找到相关数据
Single agent activity of ZW25, a HER2-targeted bispecific antibody, in heavily pretreated HER2-expressing cancers.
被引：53
作者：
Meric-Bernstam, Funda
Beeram, Murali
Mayordomo, Jose Ignacio
Hanna, Diana L.
Ajani, Jaffer A.
Murphy, Mariela A. Blum
Murthy, Rashmi Krishna
Piha-Paul, Sarina Anne
Bauer, Todd Michael
Bendell, Johanna C.
El-Khoueiry, Anthony B.
Lenz, Heinz-Josef
Press, Michael F.
Royer, Nels
Hausman, Diana Felice
Hamilton, Erika Paige
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX 77030 USA
[2] START, San Antonio, TX USA
[3] Univ Colorado, Aurora, CO USA
[4] Univ Southern Calif, Norris Comprehens Canc Ctr, Los Angeles, CA 90007 USA
[5] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[6] Sarah Cannon Res Inst, Nashville, TN USA
[7] Tennessee Oncol PLLC, Nashville, TN USA
[8] Zymeworks Inc, Vancouver, BC, Canada
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.2500
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2500
引用
收藏
页数：2
相关论文